(Q79676795)

English

In vivo evaluation of intravesical paclitaxel and combined bcl-xL antisense oligodeoxynucleotide treatment for orthotopic urothelial carcinoma

scientific article published on 22 October 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18941779%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

In vivo evaluation of intravesical paclitaxel and combined bcl-xL antisense oligodeoxynucleotide treatment for orthotopic urothelial carcinoma (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18941779%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

based on heuristic

inferred from title

author name string

Christian Bolenz

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18941779%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Christel Weiss

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18941779%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Melanie Wenzel

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18941779%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Ute Gabriel

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18941779%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Annette Steidler

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18941779%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Andreas Becker

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18941779%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Edwin Herrmann

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18941779%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Lutz Trojan

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18941779%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Maurice Stephan Michel

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18941779%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

22 October 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18941779%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18941779%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

135

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18941779%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

679-686

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18941779%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18941779%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

https://scigraph.springernature.com/pub.10.1007/s00432-008-0500-5

0 references

Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivo.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimizing chemotherapy for transitional cell carcinoma by application of bcl-2 and bcl-xL antisense oligodeoxynucleotides

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of apoptosis and chemosensitization of mesothelioma cells by Bcl-2 and Bcl-xL antisense treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of intravesical docetaxel in the management of superficial bladder cancer refractory to standard intravesical therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

siRNA agents inhibit oncogene expression and attenuate human tumor cell growth

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential expression of bcl-2 family proteins in bladder carcinomas. Relationship with apoptotic rate and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apoptosis and chemotherapy resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bladder tissue pharmacokinetics of intravesical taxol

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacologic effects of paclitaxel in human bladder tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthetic nucleic acids as potential therapeutic tools for treatment of bladder carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic antitumor activity by combined treatment with gemcitabine and antisense oligodeoxynucleotide targeting clusterin gene in an intravesical administration model against human bladder cancer kotcc-1 cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Programmed cell death and radioresistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antisense Bcl2 oligonucleotide in cisplatin-resistant bladder cancer cell lines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemosensitization of bladder carcinoma cells by bcl-xL antisense oligonucleotides

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved growth of human urothelial carcinoma cell cultures.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limited tissue penetration of taxanes: a mechanism for resistance in solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of antisense oligonucleotides in the treatment of bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of bladder cancer cells in vitro and in vivo with 2-5A antisense telomerase RNA.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Newly developed mini-endoscope for diagnosis and follow-up of orthotopic bladder transitional-cell carcinoma in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antisense oligonucleotides in the treatment of bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The health economics of bladder cancer: a comprehensive review of the published literature.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-neoplastic activity of paclitaxel on experimental superficial bladder cancer: in vivo and in vitro studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of paclitaxel released from bio-adhesive polymer microspheres on model superficial bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular distribution of phosphorothioate oligonucleotide following intravenous administration in mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxicity of cisplatin in bladder cancer is significantly enhanced by application of bcl-2 antisense oligonucleotides

1 reference

https://pubmed.ncbi.nlm.nih.gov/18941779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-008-0500-5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18941779%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18941779%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79676795&oldid=1984857204"